K110520

Substantially Equivalent

BIOLIS 12I

Applicant: Tokyo Boeki Medisys, Inc.
Product code: CEM
Advisory panel: Clinical Chemistry
Date received: 2011-02-23
Decision date: 2012-03-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Durham, NC, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.